WorldPharmaNews
Search ...
Home
Business
Research
Events
Regulatory
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
www.bms.com
.
Bristol-Myers Squibb RSS Channel
Filters
Display #
5
10
15
20
25
30
50
100
All
Filter
List of articles in category Bristol-Myers Squibb
Title
Published Date
Bristol-Myers Squibb reports fourth quarter and full year 2014 financial results
27 January 2015
Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) sign worldwide research collaboration
05 January 2015
Bristol-Myers Squibb Foundation awards nine grants to support care for high-risk patients with hepatitis B and C in China and India
03 December 2014
Bristol-Myers Squibb and Five Prime Therapeutics announce exclusive clinical collaboration
25 November 2014
Bristol-Myers Squibb to construct a new large-scale biologics manufacturing facility in Ireland
14 November 2014
Bristol-Myers Squibb enters into agreement that provides an exclusive option to acquire F-star Alpha Ltd. and its novel HER2-targeted therapy
28 October 2014
Bristol-Myers Squibb and Pfizer announce charitable donations of more than $1 million to support cardiovascular education
22 September 2014
Allied Minds and Bristol-Myers Squibb form new enterprise
07 August 2014
Bristol-Myers Squibb reports second quarter 2014 financial results
25 July 2014
Bristol-Myers Squibb and Syngene International extend research collaboration
04 June 2014
Bristol-Myers Squibb ranks first on 2014 Best Corporate Citizens List
24 April 2014
Five Prime Therapeutics and Bristol-Myers Squibb sign collaboration agreement
17 March 2014
Bristol-Myers Squibb announces charitable donation of $1 million
04 March 2014
Bristol-Myers Squibb completes previously announced sale of global diabetes business to AstraZeneca
03 February 2014
Bristol-Myers Squibb Reports fourth quarter and full year 2013 financial results
26 January 2014
AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides $5 million grant for American Diabetes Association's Pathway to Stop Diabetes
16 January 2014
Bristol-Myers Squibb to sell its global diabetes business
19 December 2013
Bristol-Myers Squibb Foundation marks World Diabetes Day with four grants addressing link between diabetes, depression and distress
14 November 2013
Bristol-Myers Squibb announces changes in its senior management team
13 November 2013
Bristol-Myers Squibb reports third quarter 2013 financial results
23 October 2013
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
Business & Industry
Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma
AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge
Pfizer invests $43 billion to battle cancer
Research & Development
'Biohybrid' device could restore function in paralysed limbs
Scientists use tardigrade proteins for human health breakthrough
DNA treatment could delay paralysis that strikes nearly all patients with ALS
Scientists reveal a potential new approach to treating liver cancer
Normalizing tumor blood vessels may improve immunotherapy against brain cancer
Engineered bacteria find tumors, then alert the authorities
First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases
Conferences & Events
SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
SAE Media Group's 6th annual 3D Cell Culture Conference
CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
CPHI Excellence in Pharma Award Winners 2022
CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
FDA grants Accelerated Approval for Alzheimer's disease treatment
FDA approves new HIV drug for adults with limited treatment options
FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
FDA approves first gene therapy to treat adults with Hemophilia B
FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
You are here:
Home
Bristol-Myers Squibb
Bristol-Myers Squibb completes divestment of manufacturing facility in Anagni, Italy